Amyris Biotechnologies, Inc. announced today that Temasek Holdings has invested $47.8 million into the company. Amyris intends to use these funds to support commercial plant design and construction activities as well as ongoing operations in the U.S. and Brazil.“We are privileged to welcome Temasek as a significant investor, and appreciate having them join us as we look to commercialize and scale our renewable fuels and chemicals,” said John Melo, chief executive officer of Amyris. Full Story
Related
Amyris Biotech Raises $48 Million - Ethiopian Review
Amyris Biotechnologies Secures $47.8M Investment from Temasek Holdings - FavStocks
Amyris gets $47.8M more for sugarcane-based biofuel - VentureBeat
Amyris Biotechnologies Secures Investment from Temasek Holdings - Green Street Journal
